Presence of varicose veins in cancer patients increases the risk for occurrence of venous thromboembolism

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 11, 2013, Pages 1993-2000

  Konigsbrugge O ^a   Lotsch F ^a   Reitter, E M ^a   Brodowicz, T ^a   Zielinski, C ^a   Pabinger, I ^a   Ay, C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Neoplasm; Risk; Thrombophlebitis; Varicose veins; Venous thromboembolism

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER PATIENT; CARDIOVASCULAR RISK; COHORT ANALYSIS; COLON CANCER; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; LEG THROMBOSIS; LUNG CANCER; LUNG EMBOLISM; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PANCREAS CANCER; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK ASSESSMENT; STOMACH CANCER; SUPERFICIAL THROMBOPHLEBITIS; VARICOSIS; VENOUS THROMBOEMBOLISM; COMPLICATION; INCIDENCE; MIDDLE AGED; NEOPLASM; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; THROMBOPHLEBITIS; TREATMENT OUTCOME;

AGED; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHLEBITIS; TREATMENT OUTCOME; VARICOSE VEINS; VENOUS THROMBOEMBOLISM;

EID: 84887559046     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12408     Document Type: Article

References (26)

1. Heit JA, Silverstein MD, Mohr DN, Petterson TA, O'Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-15.
2. Streiff MB. Anticoagulation in the management of venous thromboembolism in the cancer patient. J Thromb Thrombolysis 2011; 31: 282-94.
3. Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 2006; 24: 484-90.
4. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166: 458-64.
5. Schönauer V, Kyrle PA, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Partsch H, Eichinger S. Superficial thrombophlebitis and risk for recurrent venous thromboembolism. J Vasc Surg 2003; 37: 834-8.
6. Galanaud JP, Genty C, Sevestre MA, Brisot D, Lausecker M, Gillet J-L, Rolland C, Righini M, Leftheriotis G, Bosson J-L, Quere I. Predictive factors for concurrent deep vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. Thromb Haemost 2010; 105: 31-9.
7. Wun T, White RH. Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol 2009; 22: 9-23.
8. Kröger K, Weiland D, Ose C, Neumann N, Weiss S, Hirsch C, Urbanski K, Seeber S, Scheulen ME. Risk factors for venous thromboembolic events in cancer patients. Ann Oncol 2006; 17: 297-303.
9. Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, Moia M, Parazzini F, Rossi R, Sonaglia F, Valarani B, Bianchini C, Gussoni G. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery. Ann Surg 2006; 243: 89-95.
10. Srkalovic G, Cameron MG, Rybicki L, Deitcher SR, Kattke-Marchant K, Hussein MA. Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease. Cancer 2004; 101: 558-66.
11. Tateo S, Mereu L, Salamano S, Klersy C, Barone M, Spyropoulos A, Piovella F. Ovarian cancer and venous thromboembolic risk. Gynecol Oncol 2005; 99: 119-25.
12. Prandoni P, Lensing AWA, Piccioli A, Bernaldi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-8.
13. Ay C, Dunkler D, Simanek R, Thaler J, Koder S, Marosi C, Zielinski C, Pabinger I. Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the vienna cancer and thrombosis study. J Clin Oncol 2011; 29: 2099-103.
14. Ay C, Dunkler D, Marosi C, Chiriac AL, Vormittag R, Simanek R, Quehenberger P, Zielinski C, Pabinger I. Prediction of venous thromboembolism in cancer patients. Blood 2010; 116: 5377-82.
15. Vormittag R, Simanek R, Ay C, Dunkler D, Quehenberger P, Marosi C, Zielinski C, Pabinger I. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arterioscler Thromb Vasc Biol 2009; 29: 2176-81.
16. Kurz X, Kahn SR, Abenhaim L, Clement D, Norgren L, Baccaglini U, Berard A, Cooke JP, Cornu-Thenard A, Depairon M, Dormandy JA, Durand-Zaleski I, Fowkes GR, Lamping DL, Partsch H, Scurr JH, Zuccarelli F. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous insufficiency epidemiologic and economic studies. Int Angiol 1999; 18: 83-102.
17. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
18. Carrier M, Khorana AA, Zwicker JI, Lyman GH, Le Gal G, Lee AY; Subcommittee on Haemostasis and Malignancy for the SSC of the ISTH. Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis. J Thromb Haemost 2012; 10: 2599-601.
19. van Doormaal FF, Atalay S, Brouwer HJ, van der Felde EF, Büller HR, van Weert HC. Idiopathic superficial thrombophlebitis and the incidence of cancer in primary care patients. Ann Fam Med 2010; 8: 47-50.
20. van Weert H, Dolan G, Wichers I, de Vries C, ter Riet G, Büller HR. Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? J Fam Pract 2006; 55: 52-7.
21. Leu HJ. Phlebitides: a survey. Vasa 1994; 23: 289-98.
22. Rogers MAM, Levine DA, Blumberg N, Flanders SA, Chopra V, Langa KM. Triggers of hospitalization for venous thromboembolism. Circulation 2012; 125: 2092-9.
23. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR; American College of Chest Physicians. Antithrombotic therapy for VTE Disease: antithrombotic therapy and prevention of thrombosis, 9th American college of chest physicians evidence-based clinical practice guidelines. Chest 2012; 141(suppl 2): e419S-e494S.
24. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer N, Levine M, Mendelson D, Raskob G, Somerfield M, Thodiyil P, Trent D, Francis CW. American society of clinical oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007; 25: 5490-505.
25. Den Exter PL, Hooijer J, Dekkers OM, Huisman MV. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 2011; 29: 2405-9.
26. O'Connell CL, Razavi PA, Liebman HA. Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism. J Clin Oncol 2011; 29: 4208-9.